Ulipristal Acetate and Extracellular Matrix Production in Human Leiomyomas In Vivo: A Laboratory Analysis of a Randomized Placebo Controlled Trial
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Ulipristal Acetate and Extracellular Matrix Production in Human Leiomyomas In Vivo: A Laboratory Analysis of a Randomized Placebo Controlled Trial
Authors
Keywords
-
Journal
Reproductive Sciences
Volume 25, Issue 2, Pages 198-206
Publisher
SAGE Publications
Online
2017-09-20
DOI
10.1177/1933719117728802
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- An Evidence-based Approach to the Medical Management of Fibroids
- (2016) CHANTAL B. BARTELS et al. CLINICAL OBSTETRICS AND GYNECOLOGY
- Gonadotropin-releasing hormone analogues inhibit leiomyoma extracellular matrix despite presence of gonadal hormones
- (2016) Minnie Malik et al. FERTILITY AND STERILITY
- Mifepristone inhibits extracellular matrix formation in uterine leiomyoma
- (2016) Amrita Patel et al. FERTILITY AND STERILITY
- Mechanism of Action of Ulipristal Acetate for Emergency Contraception: A Systematic Review
- (2016) Elena Rosato et al. Frontiers in Pharmacology
- Expression of vascular endothelial factor-A, gelatinases (MMP-2, MMP-9) and TIMP-1 in uterine leiomyomas
- (2015) Porfyrios Korompelis et al. CLINICAL CHEMISTRY AND LABORATORY MEDICINE
- Efficacy and safety of repeated use of ulipristal acetate in uterine fibroids
- (2015) Jacques Donnez et al. FERTILITY AND STERILITY
- In vivo mechanisms of uterine myoma volume reduction with ulipristal acetate treatment
- (2015) Guillaume E. Courtoy et al. FERTILITY AND STERILITY
- Recruitment of Matrix Metalloproteinase-9 (MMP-9) to the Fibroblast Cell Surface by Lysyl Hydroxylase 3 (LH3) Triggers Transforming Growth Factor-β (TGF-β) Activation and Fibroblast Differentiation
- (2015) Cynthia Dayer et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Proteoglycans in Leiomyoma and Normal Myometrium
- (2015) Nichole M. Barker et al. Reproductive Sciences
- Diverse functions of matrix metalloproteinases during fibrosis
- (2014) M. Giannandrea et al. Disease Models & Mechanisms
- Ulipristal Acetate Modulates the Expression and Functions of Activin A in Leiomyoma Cells
- (2014) Pasquapina Ciarmela et al. Reproductive Sciences
- Leiomyoma Cells in 3-Dimensional Cultures Demonstrate an Attenuated Response to Fasudil, a Rho-Kinase Inhibitor, When Compared to 2-Dimensional Cultures
- (2014) Minnie Malik et al. Reproductive Sciences
- Matrix production and remodeling as therapeutic targets for uterine leiomyoma
- (2014) Caitlin Fujisawa et al. Journal of Cell Communication and Signaling
- Vitamin D3 inhibits expression and activities of matrix metalloproteinase-2 and -9 in human uterine fibroid cells
- (2013) S. K. Halder et al. HUMAN REPRODUCTION
- Pharmacokinetic evaluation of ulipristal acetate for uterine leiomyoma treatment
- (2012) Gian Benedetto Melis et al. Expert Opinion on Drug Metabolism & Toxicology
- Ulipristal Acetate versus Placebo for Fibroid Treatment before Surgery
- (2012) Jacques Donnez et al. NEW ENGLAND JOURNAL OF MEDICINE
- Ulipristal Acetate versus Leuprolide Acetate for Uterine Fibroids
- (2012) Jacques Donnez et al. NEW ENGLAND JOURNAL OF MEDICINE
- Selective progesterone receptor modulators in reproductive medicine: pharmacology, clinical efficacy and safety
- (2011) Philippe Bouchard et al. FERTILITY AND STERILITY
- Gonadotropin-releasing hormone agonist increases expression of osmotic response genes in leiomyoma cells
- (2011) Desireé M. McCarthy-Keith et al. FERTILITY AND STERILITY
- Efficacy and tolerability of CDB-2914 treatment for symptomatic uterine fibroids: a randomized, double-blind, placebo-controlled, phase IIb study
- (2010) Lynnette K. Nieman et al. FERTILITY AND STERILITY
- CDB-2914 for Uterine Leiomyomata Treatment
- (2010) Eric D. Levens et al. OBSTETRICS AND GYNECOLOGY
- Proinflammatory and Profibrotic Mediators: Principal Effectors of Leiomyoma Development as a Fibrotic Disorder
- (2010) Nasser Chegini SEMINARS IN REPRODUCTIVE MEDICINE
- Why Leiomyomas Are Called Fibroids: The Central Role of Extracellular Matrix in Symptomatic Women
- (2010) Minnie Malik et al. SEMINARS IN REPRODUCTIVE MEDICINE
- Transforming Growth Factor β3 Regulates the Versican Variants in the Extracellular Matrix-Rich Uterine Leiomyomas
- (2009) John M. Norian et al. Reproductive Sciences
- Activating transcription factor 3 gene expression suggests that tissue stress plays a role in leiomyoma development
- (2008) Mark Payson et al. FERTILITY AND STERILITY
- Progesterone receptor modulator CDB-2914 induces extracellular matrix metalloproteinase inducer in cultured human uterine leiomyoma cells
- (2008) Q. Xu et al. MOLECULAR HUMAN REPRODUCTION
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now